These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3681900)

  • 1. Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2.
    Lis R; Davey DD; Morgan TK; Lumma WC; Wohl RA; Jain VK; Wan CN; Argentieri TM; Sullivan ME; Cantor EH
    J Med Chem; 1987 Dec; 30(12):2303-9. PubMed ID: 3681900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds.
    Lis R; Morgan TK; DeVita RJ; Davey DD; Lumma WC; Wohl RA; Diamond J; Wong SS; Sullivan ME
    J Med Chem; 1987 Apr; 30(4):696-704. PubMed ID: 3560162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological studies of N-[4-[2-hydroxy-3-[[2-[4-(1H-imidazol-1- yl)phenoxy]ethyl]amino]propoxy]phenyl]methanesulfonamide, a novel antiarrhythmic agent with class II and class III activities.
    Morgan TK; Lis R; Lumma WC; Wohl RA; Nickisch K; Phillips GB; Lind JM; Lampe JW; Di Meo SV; Reiser HJ
    J Med Chem; 1990 Apr; 33(4):1087-90. PubMed ID: 2319556
    [No Abstract]   [Full Text] [Related]  

  • 4. N-[(omega-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity.
    Hester JB; Gibson JK; Cimini MG; Emmert DE; Locker PK; Perricone SC; Skaletzky LL; Sykes JK; West BE
    J Med Chem; 1991 Jan; 34(1):308-15. PubMed ID: 1992131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives.
    Butera JA; Spinelli W; Anantharaman V; Marcopulos N; Parsons RW; Moubarak IF; Cullinan C; Bagli JF
    J Med Chem; 1991 Nov; 34(11):3212-28. PubMed ID: 1956040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
    Phillips GB; Morgan TK; Lumma WC; Gomez RP; Lind JM; Lis R; Argentieri T; Sullivan ME
    J Med Chem; 1992 Feb; 35(4):743-50. PubMed ID: 1347318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterocyclic analogues of benzamide antiarrhythmic agents.
    Hanna RG; Lampe JW; Lumma WC; Erhardt PW; Wong SS; Sullivan ME
    J Med Chem; 1989 Mar; 32(3):688-93. PubMed ID: 2918518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cardiac electrophysiological activity of N-substituted-4-(1H-imidazol-1-yl)benzamides--new selective class III agents.
    Morgan TK; Lis R; Lumma WC; Nickisch K; Wohl RA; Phillips GB; Gomez RP; Lampe JW; Di Meo SV; Marisca AJ
    J Med Chem; 1990 Apr; 33(4):1091-7. PubMed ID: 2319557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class III antiarrhythmic activity of novel substituted 4-[(methylsulfonyl)amino]benzamides and sulfonamides.
    Ellingboe JW; Spinelli W; Winkley MW; Nguyen TT; Parsons RW; Moubarak IF; Kitzen JM; Von Engen D; Bagli JF
    J Med Chem; 1992 Feb; 35(4):705-16. PubMed ID: 1542097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines.
    Cross PE; Arrowsmith JE; Thomas GN; Gwilt M; Burges RA; Higgins AJ
    J Med Chem; 1990 Apr; 33(4):1151-5. PubMed ID: 2319561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents.
    Lumma WC; Wohl RA; Davey DD; Argentieri TM; DeVita RJ; Gomez RP; Jain VK; Marisca AJ; Morgan TK; Reiser HJ
    J Med Chem; 1987 May; 30(5):755-8. PubMed ID: 3572962
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.
    Phillips GB; Morgan TK; Nickisch K; Lind JM; Gomez RP; Wohl RA; Argentieri TM; Sullivan ME
    J Med Chem; 1990 Feb; 33(2):627-33. PubMed ID: 2299628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
    Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic activity of p-hydroxy-N-(2-diethylaminoethyl) benzamide (the p-hydroxy isostere of procainamide) in dogs and mice.
    Drayer DE; Slaven BH; Reidenberg MM; Bagwell EE; Cordova M
    J Med Chem; 1977 Feb; 20(2):270-4. PubMed ID: 836498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion.
    Faivre JF; Forest MC; Gout B; Bril A
    Eur J Pharmacol; 1999 Oct; 383(2):215-22. PubMed ID: 10585537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity.
    Lis R; Morgan TK; Marisca AJ; Gomez RP; Lind JM; Davey DD; Phillips GB; Sullivan ME
    J Med Chem; 1990 Oct; 33(10):2883-91. PubMed ID: 1976812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The electrophysiologic effects of ersentilide on canine hearts.
    Lee JH; Rosenshtraukh L; Beloshapko G; Rosen MR
    Eur J Pharmacol; 1995 Oct; 285(1):25-35. PubMed ID: 8846808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological studies of N-substituted 6-[(2-aminoethyl)amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinediones, novel class III antiarrhythmic agents.
    Katakami T; Yokoyama T; Miyamoto M; Mori H; Kawauchi N; Nobori T; San-nohe K; Kaiho T; Kamiya J
    J Med Chem; 1992 Sep; 35(18):3325-30. PubMed ID: 1527781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
    Johnson RE; Baizman ER; Becker C; Bohnet EA; Bell RH; Birsner NC; Busacca CA; Carabateas PM; Chadwick CC; Gruett MD
    J Med Chem; 1993 Oct; 36(22):3361-70. PubMed ID: 8230126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cardiac electrophysiological activity of 2- and 3-[(substituted phenyl)alkyl]quinuclidines. Structure-activity relationships.
    Morgan TK; Lis R; Marisca AJ; Argentieri TM; Sullivan ME; Wong SS
    J Med Chem; 1987 Dec; 30(12):2259-69. PubMed ID: 3681896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.